Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Danazol - Ampio Pharmaceuticals

Next Previous
Drug Profile

Danazol - Ampio Pharmaceuticals

Alternative Names: Optina; Vasaloc

Latest Information Update: 12 Sep 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Ampio Pharmaceuticals
  • Class Antiallergics; Eye disorder therapies; Oxazoles; Small molecules
  • Mechanism of Action Actin modulators; Capillary permeability modulators; Estrogen receptor antagonists; Testosterone congener stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Allergic rhinitis; Diabetic macular oedema; Diabetic nephropathies; Diabetic retinopathy; Wet age-related macular degeneration

Most Recent Events

  • 16 Aug 2024 Discontinued - Phase-I for Diabetic nephropathies in Canada (PO) (Ampio Pharmaceuticals Website, August 2024)
  • 16 Aug 2024 Discontinued - Phase-I/II for Allergic rhinitis in USA (Intranasal) (Ampio Pharmaceuticals Website, August 2024)
  • 16 Aug 2024 Discontinued - Phase-III for Diabetic macular oedema in USA (PO) (Ampio Pharmaceuticals Website, August 2024)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top